SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Olecranon who wrote (63238)8/21/2025 10:50:56 PM
From: stockdoc771 Recommendation

Recommended By
erippetoe

  Read Replies (2) of 63276
 
I think we need to see 1-2 quarters of stabilization and a sense that the coast is clear with regards to FDA before the stock recovers. I would be happy if we ended the year at 50. If they have good P2 data on their siRNA drugs that are due to report by end of year we could see a boost. If they guide towards 500 million in earnings for 2026 the stock could get to 100 next year.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News